Emergence of Q493R mutation in SARS-CoV-2 spike protein during bamlanivimab/etesevimab treatment and resistance to viral clearance-MedSci.cn

Emergence of Q493R mutation in SARS-CoV-2 spike protein during bamlanivimab/etesevimab treatment and resistance to viral clearance

Guigon, A; Faure, E; Lemaire, C; Chopin, MC; Tinez, C; Assaf, A; Lazrek, M; Hober, D; Bocket, L; Engelmann, I; Alidjinou, EK

Alidjinou, EK (通讯作者)，Univ Lille, Fac Med, CHU Lille, Lab Virol ULR3610,Ctr Biol Pathol, Blvd Prof Jules Leclercq, F-59000 Lille, France.

Emergence of Q493R mutation in SARS-CoV-2 spike protein during bamlanivimab/etesevimab treatment and resistance to viral clearance